Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, June 26, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Rocket Pharmaceuticals, Inc. ("Rocket Pharmaceuticals" or the "Company") (NASDAQ: RCKT) investors of a class action representing investors that bought securities between February 27, 2025 and May 26, 2025, inclusive (the "Class Period"). Tempus AI investors have until August 11, 2025 to file a lead plaintiff motion. Investors are encouraged to ...